{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-045667","form_type":"8-K","ticker":"NUS","cik":"0001021561","company_name":"NU SKIN ENTERPRISES, INC.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.403197+00:00","generated_at":"2026-05-30T03:12:59.046228+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Nu Skin Q3 revenue $430.1M (-13.8% YoY), EPS $0.17; guides lower Q4/FY","bullets":["Q3 revenue $430.1M (-13.8% YoY); customers 831,768 (-15%), paid affiliates 149,264 (-20%).","GAAP EPS $0.17 vs $(0.74); adjusted EPS $0.56 excluding prior-year inventory write-off.","Rhyz segment revenue $73.1M, up 20.9% YoY, partially offsetting Nu Skin core weakness.","Q4 guidance: rev $410-445M, non-GAAP EPS $0.19-0.29; FY24 rev $1.70-1.73B, non-GAAP EPS $0.65-0.75.","Cost-efficiency program: saved $15M in Q3, on track for $45-65M in 2024; cash from ops $31.4M."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-045667","json":"https://secwatch.observer/filing/0001140361-24-045667.json","markdown":"https://secwatch.observer/filing/0001140361-24-045667.md","text":"https://secwatch.observer/filing/0001140361-24-045667.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1021561/000114036124045667/0001140361-24-045667-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1021561/000114036124045667/ef20038263_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:12:59.046228+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}